Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Int J Tuberc Lung Dis. 2016 Feb;20(2):154–159. doi: 10.5588/ijtld.15.0319

Table 2.

Comparison of Line Probe Assay (LPA) and Phenotypic DST Results for RIF and INH, excluding Not Interpretable (NI) LPA Results.

graphic file with name nihms756074f5.jpg

R= Resistant

S= Susceptible

NI= Not Interpretable

INH= Isoniazid

RIF= Rifampicin

LPA= Line Probe Assay

DST= Drug Susceptibility Testing